Insulin responsiveness in metabolic syndrome after eight weeks of cycle training

Med Sci Sports Exerc. 2013 Nov;45(11):2021-9. doi: 10.1249/MSS.0b013e31829a6ce8.

Abstract

Introduction: Insulin resistance in obesity is decreased after successful diet and exercise. Aerobic exercise training alone was evaluated as an intervention in subjects with the metabolic syndrome.

Methods: Eighteen nondiabetic, sedentary subjects, 11 with the metabolic syndrome, participated in 8 wk of increasing intensity stationary cycle training.

Results: Cycle training without weight loss did not change insulin resistance in metabolic syndrome subjects or sedentary control subjects. Maximal oxygen consumption (V·O 2max), activated muscle AMP-dependent kinase, and muscle mitochondrial marker ATP synthase all increased. Strength, lean body mass, and fat mass did not change. The activated mammalian target of rapamycin was not different after training. Training induced a shift in muscle fiber composition in both groups but in opposite directions. The proportion of type 2× fibers decreased with a concomitant increase in type 2a mixed fibers in the control subjects, but in metabolic syndrome, type 2× fiber proportion increased and type 1 fibers decreased. Muscle fiber diameters increased in all three fiber types in metabolic syndrome subjects. Muscle insulin receptor expression increased in both groups, and GLUT4 expression increased in the metabolic syndrome subjects. The excess phosphorylation of insulin receptor substrate 1 (IRS-1) at Ser337 in metabolic syndrome muscle tended to increase further after training in spite of a decrease in total IRS-1.

Conclusions: In the absence of weight loss, the cycle training of metabolic syndrome subjects resulted in enhanced mitochondrial biogenesis and increased the expression of insulin receptors and GLUT4 in muscle but did not decrease the insulin resistance. The failure for the insulin signal to proceed past IRS-1 tyrosine phosphorylation may be related to excess serine phosphorylation at IRS-1 Ser337, and this is not ameliorated by 8 wk of endurance exercise training.

Publication types

  • Controlled Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Bicycling / physiology
  • Body Composition
  • Body Weight
  • Case-Control Studies
  • Exercise Therapy*
  • Female
  • Glucose Transporter Type 4 / metabolism
  • Humans
  • Insulin
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Resistance*
  • Male
  • Metabolic Syndrome / metabolism*
  • Metabolic Syndrome / therapy*
  • Middle Aged
  • Mitochondrial Proton-Translocating ATPases / metabolism
  • Muscle Fibers, Fast-Twitch / cytology
  • Muscle Fibers, Fast-Twitch / metabolism
  • Muscle Fibers, Slow-Twitch / cytology
  • Muscle Fibers, Slow-Twitch / metabolism
  • Muscle Strength
  • Muscle, Skeletal / cytology*
  • Muscle, Skeletal / enzymology
  • Muscle, Skeletal / metabolism*
  • Oxygen Consumption
  • Phosphorylation
  • Phosphotransferases (Phosphate Group Acceptor) / metabolism
  • Receptor, Insulin / metabolism
  • TOR Serine-Threonine Kinases / metabolism
  • Young Adult

Substances

  • Glucose Transporter Type 4
  • Insulin
  • Insulin Receptor Substrate Proteins
  • SLC2A4 protein, human
  • MTOR protein, human
  • Receptor, Insulin
  • TOR Serine-Threonine Kinases
  • AMP-dependent kinase (ATP-forming)
  • Phosphotransferases (Phosphate Group Acceptor)
  • Mitochondrial Proton-Translocating ATPases